Home › Funds › Samsara BioCapital, LLC › GOSS

Samsara BioCapital, LLC position in GOSS

GOSSAMER BIO INC · Health Care

Samsara BioCapital, LLC reported holding 7,222,559 shares of GOSS (GOSSAMER BIO INC) in its Q2 2026 13F filing — a position valued at US$1.2M, representing 0.10% of its reported portfolio and ranking #24 among its reported holdings. Samsara BioCapital, LLC has disclosed GOSS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)7.22M sh
Reported value held$1.19M
Portfolio Weight0.10%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Samsara BioCapital, LLC's GOSS position evolved

Samsara BioCapital, LLC first disclosed a stake in GOSS in Q3 2023 at 6,130,268 shares (US$5.1M). The position peaked in Q4 2025 at 7,222,559 shares, worth US$22.4M. Across 12 filings, Samsara BioCapital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 7,222,559 shares valued at US$1.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.13M $5.11M New
Q4 2023 6.13M $5.59M Hold
Q1 2024 6.13M $7.23M Hold
Q2 2024 6.13M $5.52M Hold
Q3 2024 6.13M $6.05M Hold
Q4 2024 6.13M $5.55M Hold
Q1 2025 6.13M $6.74M Hold
Q2 2025 6.13M $7.54M Hold
Q3 2025 6.13M $16.12M Hold
Q4 2025 7.22M $22.39M Add
Q1 2026 7.22M $2.37M Hold
Q2 2026 7.22M $1.19M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GOSS and 13F data

GOSS (GOSSAMER BIO INC) is a Health Care company. 9 other funds we track also report a position in GOSS — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$11.5M), Worth Venture Partners, LLC (US$4.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GOSS

All GOSS fund holders →

FAQ

How long has Samsara BioCapital, LLC held GOSS?

Samsara BioCapital, LLC has disclosed GOSS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Samsara BioCapital, LLC's current position in GOSS?

As of Q2 2026, Samsara BioCapital, LLC holds 7.22M shares of GOSS (GOSSAMER BIO INC), valued at $1.19M, representing 0.10% of its reported portfolio and ranking #24.

Has Samsara BioCapital, LLC been buying or selling GOSS?

In the latest 13F filing (Q2 2026), Samsara BioCapital, LLC held unchanged its position in GOSS. The position peaked in Q4 2025 at 7.22M shares.

Which other funds hold GOSS?

Other major institutional holders of GOSS include TANG CAPITAL MANAGEMENT LLC, Worth Venture Partners, LLC, among 9 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.